Auna 과거 순이익 실적
과거 기준 점검 1/6
Auna은 연평균 20.7%의 비율로 수입이 증가해 온 반면, Healthcare 산업은 수입이 12.2% 증가했습니다. 매출은 연평균 21.2%의 비율로 증가했습니다. Auna의 자기자본이익률은 4.3%이고 순이익률은 1.5%입니다.
핵심 정보
20.74%
순이익 성장률
12.99%
주당순이익(EPS) 성장률
| Healthcare 산업 성장률 | 8.50% |
| 매출 성장률 | 21.24% |
| 자기자본이익률 | 4.30% |
| 순이익률 | 1.52% |
| 다음 순이익 업데이트 | 18 Aug 2026 |
최근 과거 실적 업데이트
Recent updates
내러티브 업데이트 • Jun 29
AUNA: Lowered Price View And 2026 Guidance Will Frame Execution Risks
Analysts have reduced their price target on Auna to $5 from $6, citing lowered estimates following a worse-than-expected Q1 report. What’s in the News for Auna Auna reaffirmed its earnings guidance for 2026, indicating that its full-year outlook for that period remains unchanged.
내러티브 업데이트 • Jun 15
AUNA: Reaffirmed 2026 Guidance Will Challenge Bearish Reset After Q1 Setback
Analysts have trimmed their view on Auna, with the consensus price target moving down by $1 to $5, citing weaker than expected Q1 results and lower company estimates. What's in the News Auna reaffirmed earnings guidance for 2026, maintaining its outlook for the full year.
내러티브 업데이트 • Jun 01
AUNA: Mexico Execution And 2026 Guidance Will Drive Bullish Re Rating
Analysts have reduced their price target on Auna by $1 to $5, reflecting updated assumptions for fair value, discount rate, growth, margins, and future P/E following a worse than expected Q1 report. What's in the News Auna issued new earnings guidance for fiscal year 2026, projecting revenue growth of about 12% on a constant currency basis, within a range of 10% to 14%.Seeking Alpha • May 29
Auna: A Discounted Hospital Operator With An Insurance Twist
Summary Auna trades at depressed valuations despite a stable, integrated insurance and hospital business spanning Peru, Colombia, and Mexico. Operational setbacks in Mexico and Colombia have pressured results, but recent management actions and Q1 trends indicate stabilization and recovery potential. AUNA’s leverage remains high (net debt/EBITDA 3.7x), but recent debt restructuring, improved cash generation, and reduced capex support deleveraging. With a P/FCF of 1.9x and P/E of 5x (2026E), AUNA offers material upside if operational and macro risks continue to abate. Read the full article on Seeking Alpha분석 기사 • May 28
Some Investors May Be Willing To Look Past Auna's (NYSE:AUNA) Soft Earnings
Investors were disappointed with the weak earnings posted by Auna S.A. ( NYSE:AUNA ). Despite the soft profit numbers...내러티브 업데이트 • May 04
AUNA: Execution On 2026 Guidance Will Drive Reassessment Of Bearish Reset
Analysts have reduced their price target on Auna from $19.00 to $9.00, citing updated assumptions for discount rate, revenue growth, profit margins, and a lower future P/E following recent bearish Street research. Analyst Commentary Even with the lower headline target, some bullish analysts still see room for upside if Auna can deliver on key execution milestones and support the revised valuation assumptions.내러티브 업데이트 • Apr 19
AUNA: Mexico Execution And 2026 Guidance Will Support Bullish Re‑Rating
Analysts have maintained their price target on Auna at $7.20, citing a mix of more cautious and more optimistic research views that reflect slightly updated assumptions for discount rates, growth and P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts point to the current $7.20 target as reasonable relative to their updated P/E assumptions, suggesting the valuation still lines up with their expectations for the business model and capital allocation.내러티브 업데이트 • Apr 05
AUNA: Mexico Execution And 2026 Guidance Will Support Long-Term Upside
Analysts have trimmed their price target for Auna from about $10.42 to $7.20, reflecting updated views on discount rates, revenue growth, profit margins and future P/E, following a mix of recent bullish and bearish research updates. Analyst Commentary Recent research on Auna shows a mix of optimism and caution, which helps explain the reduced price target and the current debate around the shares.내러티브 업데이트 • Mar 22
AUNA: Mixed Research Views And 2026 Guidance Will Shape Execution Outlook
Auna's analyst price target has been updated to $6.00, with analysts citing mixed recent research that includes a more cautious stance from BTG Pactual, along with more constructive views from HSBC and Jefferies on the company outlook. Analyst Commentary Recent Street research on Auna points to a split view, with some analysts turning more constructive while others are sounding more cautious and adjusting ratings and price targets accordingly.내러티브 업데이트 • Mar 08
AUNA: Execution On Mixed Research Views Will Shape Future Upside Potential
Analysts have trimmed their Auna price target to $6.00, reflecting slightly adjusted assumptions around the discount rate, revenue growth, profit margins and future P/E after a mix of more cautious and more constructive recent research views. Analyst Commentary Recent research views on Auna have moved in different directions, with some firms turning more constructive and at least one becoming more cautious.내러티브 업데이트 • Feb 22
AUNA: Execution On Mixed Mexico Expansion Views Will Drive Future Upside
Analysts have nudged their price target on Auna up from $6.00 to $6.50, reflecting mixed but generally constructive research, with one firm turning more cautious even as others highlight potential for slightly better growth, margins, and a lower assumed future P/E. Analyst Commentary Recent research has not been uniformly positive, and some bearish analysts are clearly leaning more cautious on Auna, even as others highlight potential upside.내러티브 업데이트 • Feb 07
AUNA: Mexico Expansion And Leverage Execution Will Drive Upside Potential
Analysts have reduced their price target on Auna to $6.00 from $13.50, reflecting a more cautious stance as they weigh concerns about a slower ramp up in Mexico, elevated leverage, and mixed recent rating changes from BTG Pactual, HSBC, and Jefferies. Analyst Commentary Recent research shows a split in views on Auna, with some firms taking a more constructive stance while others highlight execution and balance sheet risks.내러티브 업데이트 • Jan 24
AUNA: Mexico Execution And Leverage Path Will Shape Balanced Upside Potential
Analysts have lifted their Auna price target to $6.00 from $6.00, keeping the fair value level steady while adjusting their view to reflect updated assumptions on discount rates, revenue growth, profit margins and future P/E in light of mixed but generally constructive recent research. Analyst Commentary Recent research on Auna has been mixed, with some firms taking a more constructive stance while others highlight ongoing execution and balance sheet questions.분석 기사 • Jan 23
Does Auna (NYSE:AUNA) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...내러티브 업데이트 • Jan 10
AUNA: Mexico Expansion Will Reframe Perceived Execution And Leverage Risks
Analysts have trimmed their price target on Auna to US$6 from US$13.50, pointing to a slower ramp-up in Mexico, a less supportive consolidated growth profile, and expectations that leverage will remain elevated. Analyst Commentary Recent Street research on Auna has turned more cautious, with JPMorgan cutting its rating to Neutral and lowering its price target to US$6 from US$13.50.내러티브 업데이트 • Dec 22
AUNA: Mexico Execution And Deleveraging Will Drive Long-Term Upside Potential
Analysts have trimmed their price target on Auna by roughly $0.25 to reflect a slightly lower fair value estimate and a modestly higher discount rate, citing concerns over slower than expected growth and sustained leverage highlighted in recent research. Analyst Commentary Analyst reactions to the latest developments at Auna have focused on the trade off between long term growth optionality and near term execution risks, particularly around the company's regional expansion and balance sheet trajectory.내러티브 업데이트 • Dec 08
AUNA: Mexico Expansion And Deleveraging Will Unlock Future Upside Potential
Analysts have lowered their price target on Auna from $13.50 to $6.00, citing a slower than expected ramp-up in Mexico, a less compelling consolidated growth profile, and persistently elevated leverage. Analyst Commentary Analyst views on Auna have turned more cautious following the recent downgrade and target price cut to $6.00, but the stock’s reset valuation is also seen as creating a more balanced risk reward profile.내러티브 업데이트 • Nov 24
AUNA: Future Expansion Plans In Mexico Will Unlock Growth Potential
Narrative Update: Analyst Price Target Change for Auna The average analyst price target for Auna was reduced from $12.08 to $10.67. Analysts point to a slower than expected operational ramp-up and persistent elevated leverage as key factors for the adjustment.분석 기사 • Nov 14
Auna (NYSE:AUNA) Is Looking To Continue Growing Its Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...새로운 내러티브 • May 29
High-Efficiency Healthcare Model And Demographic Trends Will Shape Future Landscape
Operational challenges in Mexico are being addressed, while strong performance in Peru showcases the potential of Auna's value-based, integrated care model.분석 기사 • Jan 29
A Piece Of The Puzzle Missing From Auna S.A.'s (NYSE:AUNA) 26% Share Price Climb
The Auna S.A. ( NYSE:AUNA ) share price has done very well over the last month, posting an excellent gain of 26%. While...분석 기사 • Jan 19
Here's Why Auna (NYSE:AUNA) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Seeking Alpha • Jan 15
Auna: Cheap Entry Level In Latin American Healthcare Play
Summary Auna is a leading player in the Spanish-speaking Latin America medical industry, focusing particularly on high-complexity diseases, such as cancer. Most SSLA have a highly fragmented and underserved healthcare market, and populations are becoming elderly, demanding more and better services. AUNA stock has been impacted negatively following its IPO process, as local institutional players such as pension funds overbought the stock and had to sell due to regulatory limits. AUNA stock trades currently below 6X EV / EBITDA, while revenues and EBITDA are growing at double digits. Patient investors should benefit from valuation normalization metrics and continued growth. Though it still has high leverage (Net Debt / EBITDA =3.7), it has been able to decrease it (from 6.8X in 2021) and has stable and growing operating cash flows (annual run rate USD250MM last quarter). Interest rate reductions should benefit the company. Read the full article on Seeking Alpha매출 및 비용 세부 내역
매출 및 비용 세부 내역
Auna가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 31 Mar 26 | 4,521 | 69 | 1,115 | 0 |
| 31 Dec 25 | 4,385 | 98 | 1,082 | 0 |
| 30 Sep 25 | 4,316 | 187 | 1,042 | 0 |
| 30 Jun 25 | 4,325 | 237 | 1,053 | 0 |
| 31 Mar 25 | 4,352 | 159 | 1,035 | 0 |
| 31 Dec 24 | 4,386 | 110 | 1,027 | 0 |
| 30 Sep 24 | 4,344 | -123 | 1,006 | 0 |
| 30 Jun 24 | 4,233 | -261 | 964 | 0 |
| 31 Mar 24 | 4,058 | -263 | 956 | 0 |
| 31 Dec 23 | 3,876 | -254 | 902 | 0 |
| 30 Sep 23 | 3,659 | -112 | 836 | 0 |
| 30 Jun 23 | 3,241 | -76 | 769 | 0 |
| 31 Mar 23 | 2,861 | -100 | 674 | 0 |
| 31 Dec 22 | 2,452 | -86 | 620 | 0 |
| 30 Sep 22 | 2,118 | -65 | 626 | 0 |
| 30 Jun 22 | 2,009 | -64 | 604 | 0 |
| 31 Mar 22 | 1,937 | -35 | 594 | 0 |
| 31 Dec 21 | 1,924 | -26 | 586 | 0 |
| 30 Sep 21 | 1,874 | 20 | 536 | 0 |
| 30 Jun 21 | 1,779 | 42 | 494 | 0 |
| 31 Mar 21 | 1,577 | 51 | 449 | 0 |
| 31 Dec 20 | 1,444 | -7 | 421 | 0 |
| 30 Sep 20 | 1,373 | 28 | 396 | 0 |
| 30 Jun 20 | 1,335 | 14 | 388 | 0 |
| 31 Mar 20 | 1,381 | 16 | 385 | 0 |
| 31 Dec 19 | 1,383 | 73 | 375 | 0 |
| 31 Dec 18 | 861 | 36 | 271 | 0 |
| 31 Dec 17 | 723 | 22 | 244 | 0 |
양질의 수익: AUNA는 PEN63.1M 규모의 큰 일회성 손실이 있어 31st March, 2026까지 지난 12개월 재무 결과에 영향을 미쳤습니다.
이익 마진 증가: AUNA의 현재 순 이익률 (1.5%)은 지난해 (3.7%)보다 낮습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: AUNA는 지난 5년 동안 흑자전환하며 연평균 20.7%의 수익 성장을 기록했습니다.
성장 가속화: AUNA은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.
수익 대 산업: AUNA은 지난 1년 동안 수익이 감소(-56.8%)하여 Healthcare 업계 평균(17.3%)과 비교하기 어렵습니다.
자기자본이익률
높은 ROE: AUNA의 자본 수익률(4.3%)은 낮음으로 평가됩니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/08/07 17:23 |
| 종가 | 2026/08/07 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Auna S.A.는 7명의 분석가가 다루고 있습니다. 이 중 6명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Samuel Campos Alves | BTG Pactual |
| Leandro Bastos | Citigroup Inc |
| Raj Sinha | HSBC |